What is the current stock price of Herantis Pharma Oyj (HRPMF)?

As of the latest market data, Herantis Pharma Oyj (HRPMF) is trading at $3.51. The stock has seen a loss of 0.00% today.

Does Herantis Pharma Oyj (HRPMF) pay a dividend?

Based on current data, Herantis Pharma Oyj does not have a confirmed active dividend policy.

What is the market cap of Herantis Pharma Oyj?

The current market capitalization of Herantis Pharma Oyj (HRPMF) is approximately unavailable.

HRPMF

Herantis Pharma Oyj·Healthcare

3.51

0.000%(+0.00)

Close Price

Last Updated: — ET

52W L: $3.5152W H: $3.51

Company Profile

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2018-10-30

Beta

0.43

Websitewww.herantis.com↗